Bayer wins US FDA approval for Sunharbo to reduce repeat strokes
Résumé détaillé
The US Food and Drug Administration on Monday approved a new type of blood thinner developed by Bayer for the prevention of strokes in patients who have alre ...
Sunharbo is approved as a once-daily treatment to prevent another stroke in patients whose previous stroke was not caused by a clot from the heart.
The drug, which has the chemical name asundexian and will be sold under the brand name Sunharbo, is the first approved treatment designed to prevent harmful blood clots by blocking the clotting protein Factor XIa. (Representational image: Unsplash)
Début de l'article, extrait de Emirates 24/7. Pour lire la suite, ouvrez l'article chez le média.
MarketNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (www.emirates247.com)
